ROCKET DOCTOR AI INC. ANNOUNCES CLOSING OF LISTED ISSUER FINANCING EXEMPTION (LIFE) PRIVATE PLACEMENT OF UNITS

Executive Summary

• Rocket Doctor AI Inc. closed a non‑brokered private placement of 7,428,571 units at C$0.70 per unit, raising approximately C$5.2 million in gross proceeds.
• Each unit includes one common share and one warrant to purchase an additional common share at C$0.85, exercisable until January 22 2027.
• Net proceeds will be allocated to digital marketing, customer acquisition, operating & administrative expenses (including salaries), research & development, and general working capital.

Key Details

• Units sold: 7,428,571 units @ C$0.70 per unit → gross proceeds ≈ C$5,200,000.
• Unit composition: 1 common share + 1 common‑share purchase warrant (exercise price C$0.85).
• Warrant terms: Exercisable at any time until January 22 2027; each warrants one additional common share.
• Finder’s commission paid: C$198,800 cash to certain finders.
• Additional warrants issued: 284,000 non‑transferable warrants (exercise price C$0.85) issued as part of the placement.
• Exemption used: Listed issuer financing exemption under NI 45‑106 Part 5A and Coordinated Blanket Order 45‑935; securities not subject to a hold period in Canada.
• Use of proceeds:
• Digital marketing & customer acquisition expenses
• Operating & administrative costs (including salaries)
• Research & development activities
• General working capital
• Regulatory notice: Securities were not and will not be registered under the U.S. Securities Act; cannot be offered or sold in the United States except pursuant to an exemption or registration.

Notable Quotes

“We are appreciative of our investors for the very strong demand for this raise. These funds will help us unlock the next chapter at this critical inflection point for our company, providing the resources necessary to scale our operations and specifically drive our growth strategy within the U.S.” – Dr. Essam Hamza, CEO, Rocket Doctor AI Inc.